NCT03149939已完成不适用
Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 19
- 主要终点
- Change in serum uric acid
研究概览
简要总结
Hyperuricemia is not infrequently encountered among hemodialysis patients. However, there is no clear data about use of febuxostat among hemodialysis patients, apart from very small case series. The aim of this study is to investigate the efficacy of using febuxostat for the treatment of Hyperuricemia among hemodialysis patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age above 18 years
- •Hemodialysis patient
- •Hyperuricemia (Uric acid level above 6.0 mg/dL in females and 7.0 mg/dL in males)
排除标准
- •Patient currently and/or recently received drugs for hyperuricemia within the last three months
- •Patient had recent (within 3 months) change of erythropoiesis stimulating drugs or other drug known to increase uric acid e.g furosemide
结局指标
主要结局
Change in serum uric acid
时间窗: at three months of Febuxostat 40 milligrams Tablet therapy
Change in serum uric acid after 3 months of Febuxostat 40 milligrams Tablet therapy
次要结局
未报告次要终点
研究者
Mahmoud Hamada imam
MD. - Lecturer at Internal Medicine Department- Faculty of Medicine
Benha University
相似试验
已完成
3 期
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutHyperuricemia With or Without GoutNCT03372200Mochida Pharmaceutical Company, Ltd.203
已完成
不适用
Effect of Febuxostat on Flow Mediated Diameter in hyperuricemia patients with chronic kidney disease 5D.hyperuricemiaJPRN-UMIN000014787Tsuruta clinic50
招募中
4 期
Survey of dotinurad use in hyperuricemic patients with impaired renal function-A retrospective observational studyPatients with hyperuricemia (renal function as eGFR category G1-G5)JPRN-jRCT1051230149Shimazu keiji500
招募中
1 期
Study to find out if the drug Lumasiran can be used for patients on haemodialysis with high oxalate levels in the blood.EUCTR2022-002681-32-DECharité Universitätsmedizin Berlin60
终止
不适用
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot StudyBlood PressureGoutNCT01701622University of Mississippi Medical Center1